Early living-donor kidney transplantation: A review of the associated survival benefit

Transplantation

Volumn 87, Issue 3, 2009, Pages 317-318

  Liem, Ylian S ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; LIVING DONOR; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SHORT SURVEY; HOSPITAL ADMISSION; IMMUNOLOGY; PHYSIOLOGY; REVIEW; SURVIVOR;

GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; RENAL REPLACEMENT THERAPY; SURVIVORS; WAITING LISTS;

EID: 61849099982     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181952710     Document Type: Short Survey

References (13)

1. Liem YS, Bosch JL, Arends LR, et al. Quality of life assessed with the medical outcomes study short form 36-item health survey of patients on renal replacement therapy: A systematic review and meta-analysis. Value Health 2007; 10: 390.
2. Katz SM, Kerman RH, Golden D, et al. Preemptive transplantation - An analysis of benefits and hazards in 85 cases. Transplantation 1991; 51: 351.
3. Abecassis M, Bartlett ST, Collins AJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: A national kidney foundation/kidney disease outcomes quality initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol 2008; 3: 471.
4. ERA-EDTARegistry. Annual report 2005: European Renal Association -European Dialysis and Transplant Association, 2005.
5. US Renal Data System. USRDS 2007 Annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2007.
6. Weng FL, Mange KC. A comparison of persons who present for preemptive and nonpreemptive kidney transplantation. Am J Kidney Dis 2003; 42: 1050.
7. Meier-Kriesche HU, Kaplan B. Waiting timeondialysis asthe strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002; 74: 1377.
8. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001; 344: 726.
9. Gill JS, Tonelli M, Johnson N, et al. Why do preemptive kidney transplant recipients have an allograft survival advantage? Transplantation 2004; 78: 873.
10. Ishani A, Ibrahim HN, Gilbertson D, et al. The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants. Am J Kidney Dis 2003; 42: 1275.
11. Kasiske BL, Snyder JJ, Matas AJ, et al. Preemptive kidney transplantation: The advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358.
12. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, et al. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant 2005; 20: 167.
13. Weimar W, Homan van der Heide J, de Fijter J, et al. Calculation of survival from the first day of renal replacement therapy (RRT) justifies propaganda fro pre-emptive transplantation. Am J Transplant 2007; 7(suppl 2): 236.